e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.40p
   
  • Change Today:
    -0.35p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 4,821,033
  • Market Cap: £54.93m

Deal with Barclays    Trade now with Barclays Stockbrokers

e-Therapeutics Overview

e-Therapeutics is in the pharma and biotech sector and is currently trading at 9.40p per share. In the last year e-Therapeutics's share price has ranged from 8.13p to 23.10p.

1 Day Chart (03-05-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2155.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 115.6 n/a
Pr/Book 1.7  
Latest F'cast
Revenue -0.4% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

e-Therapeutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-19 0.04 (5.09) (1.49)p n/a n/a n/a n/a 0.0%
31-Jan-20 0.46 (2.87) (0.87)p n/a n/a n/a n/a 0.0%
31-Jan-21 0.32 (4.47) (0.99)p n/a n/a n/a n/a 0.0%
31-Jan-22 0.48 (9.52) (1.65)p n/a n/a n/a n/a 0.0%
31-Jan-23 0.47 (9.77) (1.54)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

e-Therapeutics Company Announcements

e-therapeutics 03-May-2024 18:00 RNS
Result of General Meeting 29-Apr-2024 14:09 RNS
Proposed Fundraise of £28.9m and Cancellation 10-Apr-2024 07:00 RNS

e-Therapeutics ShareCast News

e-Therapeutics proposes £29m fundraising, delist... 10-Apr-2024 ShareCast
E-Therapeutics enters collaboration with Arcturi... 02-Nov-2023 ShareCast
Eight new patent applications filed by e-therape... 01-Aug-2022 ShareCast

Latest e-Therapeutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.40p
Change Today -0.35p
% Change -3.59 %
52 Week High 23.10
52 Week Low 8.13
Volume 4,821,033
Shares Issued 584.34m
Market Cap £54.93m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average21.53% below the market average
60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average
Price Trend
60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average60.02% below the market average
5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average5.45% above the sector average
Income Not Available
Growth
15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average15.57% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
12:33 1,834,972 @ 9.25p
16:10 25,000 @ 9.50p
15:45 54,184 @ 9.65p
15:45 54,184 @ 9.60p
15:45 54,184 @ 9.65p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page